← Insider buys
KRTX

Karuna Therapeutics, Inc.

Chief Medical Officer Stephen K. Brannan sold $4.8M of Karuna Therapeutics, Inc.

Sold$4,752,150
$316.81Price
15,000Shares
−28%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Mon, Jan 8. Filed Tue, Jan 9, 11:34 AM ET, during the session. Not investment advice.